# Sickle Cell Disease, Hemechip

> **NCT03948516** · — · COMPLETED · sponsor: **University Hospitals Cleveland Medical Center** · enrollment: 738 (actual)

## Conditions studied

- Sickle Cell Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03948516
- **Lead sponsor:** University Hospitals Cleveland Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-11
- **Primary completion:** 2018-04-26
- **Final completion:** 2018-04-26
- **Target enrollment:** 738 (ACTUAL)
- **Last updated:** 2025-08-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03948516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03948516, "Sickle Cell Disease, Hemechip". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03948516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*